company background image
PHRM logo

PharmaTher Holdings CNSX:PHRM Stock Report

Last Price

CA$0.35

Market Cap

CA$30.9m

7D

7.7%

1Y

169.2%

Updated

24 Mar, 2024

Data

Company Financials

PharmaTher Holdings Ltd.

CNSX:PHRM Stock Report

Market Cap: CA$30.9m

PHRM Stock Overview

PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes.

PHRM fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

PharmaTher Holdings Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for PharmaTher Holdings
Historical stock prices
Current Share PriceCA$0.35
52 Week HighCA$0.43
52 Week LowCA$0.08
Beta3.02
1 Month Change79.49%
3 Month Change22.81%
1 Year Change169.23%
3 Year Change45.83%
5 Year Changen/a
Change since IPO79.49%

Recent News & Updates

Here's Why We're Not Too Worried About PharmaTher Holdings' (CSE:PHRM) Cash Burn Situation

Dec 31
Here's Why We're Not Too Worried About PharmaTher Holdings' (CSE:PHRM) Cash Burn Situation

Recent updates

Here's Why We're Not Too Worried About PharmaTher Holdings' (CSE:PHRM) Cash Burn Situation

Dec 31
Here's Why We're Not Too Worried About PharmaTher Holdings' (CSE:PHRM) Cash Burn Situation

Shareholder Returns

PHRMCA PharmaceuticalsCA Market
7D7.7%13.4%0.6%
1Y169.2%39.9%10.3%

Return vs Industry: PHRM exceeded the Canadian Pharmaceuticals industry which returned 39.8% over the past year.

Return vs Market: PHRM exceeded the Canadian Market which returned 10.3% over the past year.

Price Volatility

Is PHRM's price volatile compared to industry and market?
PHRM volatility
PHRM Average Weekly Movement19.7%
Pharmaceuticals Industry Average Movement13.8%
Market Average Movement8.5%
10% most volatile stocks in CA Market18.6%
10% least volatile stocks in CA Market3.1%

Stable Share Price: PHRM's share price has been volatile over the past 3 months.

Volatility Over Time: PHRM's weekly volatility (20%) has been stable over the past year, but is still higher than 75% of Canadian stocks.

About the Company

FoundedEmployeesCEOWebsite
2019n/aFabio Chianellihttps://www.pharmather.com

PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company’s product pipeline includes KETARX, a hydrochloride injection for the treatment of Parkinson’s disease, Amyotrophic Lateral Sclerosis, complex regional pain and Rett syndrome, and anesthesia and procedural sedation, as well as Ischemia reperfusion injury. It also develops KETARX, a microneedle patch, for mental health, neurological, and pain disorders; and KETARX On-body pump for the maintenance of general anesthesia for diagnostic and surgical procedures.

PharmaTher Holdings Ltd. Fundamentals Summary

How do PharmaTher Holdings's earnings and revenue compare to its market cap?
PHRM fundamental statistics
Market capCA$30.86m
Earnings (TTM)-CA$4.74m
Revenue (TTM)n/a

0.0x

P/S Ratio

-6.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PHRM income statement (TTM)
RevenueCA$0
Cost of RevenueCA$0
Gross ProfitCA$0
Other ExpensesCA$4.74m
Earnings-CA$4.74m

Last Reported Earnings

Nov 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.054
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0%

How did PHRM perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.